Skip to main content
Erschienen in: World Journal of Urology 9/2023

08.07.2023 | Original Article

Urinary microbiome differences between lichen sclerosus induced and non-lichen sclerosus induced urethral stricture disease

verfasst von: Marcus L. Jamil, Aaron Perecman, Amanda Sherman, Travis Sullivan, Kimberly Christ, Alexandra Hansma, Eric Burks, Alex J. Vanni

Erschienen in: World Journal of Urology | Ausgabe 9/2023

Einloggen, um Zugang zu erhalten

Abstract

Objective

To describe differences in the urinary microbiome of patients with pathologically confirmed lichen sclerosus (LS) urethral stricture disease (USD) vs non-lichen sclerosus (non-LS) USD pre- and post-operatively.

Methods

Patients were pre-operatively identified and prospectively followed, all underwent surgical repair and had tissue samples obtained to make a pathological diagnosis of LS. Pre- and post-operative urine samples were collected. Bacterial genomic DNA was extracted. Alpha and beta diversity measurements were calculated and compared. A zero-inflated negative binomial model was utilized to compare taxa abundances between disease status and surgery status.

Results

Urine samples were obtained from both cohorts, 69 samples in total: 36 samples were obtained pre-operatively and 33 samples were obtained post-operatively. Ten patients provided both a pre-operative and post-operative urine sample. Twenty-six patients had pathological evidence of LS and 33 patients did not. There was a statistically significant difference in alpha diversity between the pre-operative urine samples of patients with non-LS USD and LS USD, (p = 0.01). There was no significant difference in alpha diversity within post-operative urine samples between patients with non-LS USD and LS USD, (p = 0.1). A significant difference was observed in Weighed UniFrac distances with respect to disease and operative status, (p = 0.001 and 0.002).

Conclusions

LS USD have significant alterations in diversity and differential abundance of urine microbiota compared to non-LS USD controls. These findings could be used to guide further investigations into the role of the urinary microbiome in LS USD pathogenesis, severity of presentation, and stricture recurrence.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Relman DA (2015) The human microbiome and the future practice of medicine. JAMA 314(11):1127–1128CrossRefPubMed Relman DA (2015) The human microbiome and the future practice of medicine. JAMA 314(11):1127–1128CrossRefPubMed
3.
Zurück zum Zitat Aragón IM, Herrera-Imbroda B, Queipo-Ortuño MI et al (2018) The urinary tract microbiome in health and disease. Eur Urol Focus 4(1):128–138CrossRefPubMed Aragón IM, Herrera-Imbroda B, Queipo-Ortuño MI et al (2018) The urinary tract microbiome in health and disease. Eur Urol Focus 4(1):128–138CrossRefPubMed
4.
Zurück zum Zitat Whiteside SA, Razvi H, Dave S et al (2015) The microbiome of the urinary tract–a role beyond infection. Nat Rev Urol 12(2):81–90CrossRefPubMed Whiteside SA, Razvi H, Dave S et al (2015) The microbiome of the urinary tract–a role beyond infection. Nat Rev Urol 12(2):81–90CrossRefPubMed
5.
Zurück zum Zitat Lewis DA, Brown R, Williams J et al (2013) The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults. Front Cell Infect Microbiol 3:41CrossRefPubMedPubMedCentral Lewis DA, Brown R, Williams J et al (2013) The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults. Front Cell Infect Microbiol 3:41CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Drake MJ, Morris N, Apostolidis A et al (2017) The urinary microbiome and its contribution to lower urinary tract symptoms; ICI-RS 2015. Neurourol Urodyn 36(4):850–853CrossRefPubMed Drake MJ, Morris N, Apostolidis A et al (2017) The urinary microbiome and its contribution to lower urinary tract symptoms; ICI-RS 2015. Neurourol Urodyn 36(4):850–853CrossRefPubMed
8.
Zurück zum Zitat Shoskes DA, Altemus J, Polackwich AS et al (2016) The Urinary microbiome differs significantly between patients with chronic prostatitis/chronic pelvic pain syndrome and controls as well as between patients with different clinical phenotypes. Urology 92:26–32CrossRefPubMed Shoskes DA, Altemus J, Polackwich AS et al (2016) The Urinary microbiome differs significantly between patients with chronic prostatitis/chronic pelvic pain syndrome and controls as well as between patients with different clinical phenotypes. Urology 92:26–32CrossRefPubMed
9.
Zurück zum Zitat Pearce MM, Hilt EE, Rosenfeld AB et al (2014) The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. MBio 5(4):14CrossRef Pearce MM, Hilt EE, Rosenfeld AB et al (2014) The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. MBio 5(4):14CrossRef
10.
11.
Zurück zum Zitat Kachroo N, Lange D, Penniston Kristina L et al (2021) Meta-analysis of clinical microbiome studies in urolithiasis reveal age, stone composition, and study location as the predominant factors in urolithiasis-associated microbiome composition. MBio 12(4):e02007-21CrossRefPubMedPubMedCentral Kachroo N, Lange D, Penniston Kristina L et al (2021) Meta-analysis of clinical microbiome studies in urolithiasis reveal age, stone composition, and study location as the predominant factors in urolithiasis-associated microbiome composition. MBio 12(4):e02007-21CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Dong Q, Nelson DE, Toh E et al (2011) The microbial communities in male first catch urine are highly similar to those in paired urethral swab specimens. PLoS ONE 6(5):e19709CrossRefPubMedPubMedCentral Dong Q, Nelson DE, Toh E et al (2011) The microbial communities in male first catch urine are highly similar to those in paired urethral swab specimens. PLoS ONE 6(5):e19709CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Cohen AJ, Gaither TW, Srirangapatanam S et al (2021) Synchronous genitourinary lichen sclerosus signals a distinct urinary microbiome profile in men with urethral stricture disease. World J Urol 39(2):605–611CrossRefPubMed Cohen AJ, Gaither TW, Srirangapatanam S et al (2021) Synchronous genitourinary lichen sclerosus signals a distinct urinary microbiome profile in men with urethral stricture disease. World J Urol 39(2):605–611CrossRefPubMed
14.
Zurück zum Zitat Schirmer M, Smeekens SP, Vlamakis H et al (2016) Linking the HUMAN GUT MICROBIOME TO INFLAMMATORY CYTOKINE PRODUCTION CAPACITY. Cell 167(4):1125-1136.e8CrossRefPubMedPubMedCentral Schirmer M, Smeekens SP, Vlamakis H et al (2016) Linking the HUMAN GUT MICROBIOME TO INFLAMMATORY CYTOKINE PRODUCTION CAPACITY. Cell 167(4):1125-1136.e8CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Pugliese JM, Morey AF, Peterson AC (2007) Lichen sclerosus: review of the literature and current recommendations for management. J Urol 178(6):2268–2276CrossRefPubMed Pugliese JM, Morey AF, Peterson AC (2007) Lichen sclerosus: review of the literature and current recommendations for management. J Urol 178(6):2268–2276CrossRefPubMed
16.
Zurück zum Zitat Patel CK, Buckley JC, Zinman LN et al (2016) Outcomes for management of lichen sclerosus urethral strictures by 3 different techniques. Urology 91:215–221CrossRefPubMed Patel CK, Buckley JC, Zinman LN et al (2016) Outcomes for management of lichen sclerosus urethral strictures by 3 different techniques. Urology 91:215–221CrossRefPubMed
17.
Zurück zum Zitat Liu JS, Walker K, Stein D et al (2014) Lichen sclerosus and isolated bulbar urethral stricture disease. J Urol 192(3):775–779CrossRefPubMed Liu JS, Walker K, Stein D et al (2014) Lichen sclerosus and isolated bulbar urethral stricture disease. J Urol 192(3):775–779CrossRefPubMed
18.
Zurück zum Zitat Levy A, Browne B, Fredrick A et al (2019) Insights into the pathophysiology of urethral stricture disease due to lichen sclerosus: comparison of pathological markers in lichen sclerosus induced strictures vs nonlichen sclerosus induced strictures. J Urol 201(6):1158–1163CrossRefPubMed Levy A, Browne B, Fredrick A et al (2019) Insights into the pathophysiology of urethral stricture disease due to lichen sclerosus: comparison of pathological markers in lichen sclerosus induced strictures vs nonlichen sclerosus induced strictures. J Urol 201(6):1158–1163CrossRefPubMed
19.
Zurück zum Zitat Dubey D, Sehgal A, Srivastava A et al (2005) Buccal mucosal urethroplasty for balanitis xerotica obliterans related urethral strictures: the outcome of 1 and 2-stage techniques. J Urol 173(2):463–466CrossRefPubMed Dubey D, Sehgal A, Srivastava A et al (2005) Buccal mucosal urethroplasty for balanitis xerotica obliterans related urethral strictures: the outcome of 1 and 2-stage techniques. J Urol 173(2):463–466CrossRefPubMed
20.
Zurück zum Zitat Thomas-White KJ, Hilt EE, Fok C et al (2016) Incontinence medication response relates to the female urinary microbiota. Int Urogynecol J 27(5):723–733CrossRefPubMed Thomas-White KJ, Hilt EE, Fok C et al (2016) Incontinence medication response relates to the female urinary microbiota. Int Urogynecol J 27(5):723–733CrossRefPubMed
21.
Zurück zum Zitat Erickson BA, Flynn KJ, Hahn AE et al (2020) Development and validation of a male anterior urethral stricture classification system. Urology 143:241–247CrossRefPubMed Erickson BA, Flynn KJ, Hahn AE et al (2020) Development and validation of a male anterior urethral stricture classification system. Urology 143:241–247CrossRefPubMed
22.
Zurück zum Zitat Levy AC, Moynihan M, Bennett JA et al (2020) Protein expression profiles among lichen sclerosus urethral strictures-can urethroplasty success be predicted? J Urol 203(4):773–778CrossRefPubMed Levy AC, Moynihan M, Bennett JA et al (2020) Protein expression profiles among lichen sclerosus urethral strictures-can urethroplasty success be predicted? J Urol 203(4):773–778CrossRefPubMed
23.
Zurück zum Zitat Granieri MA, Peterson AC, Madden-Fuentes RJ (2017) Effect of lichen sclerosis on success of urethroplasty. Urol Clin N Am 44(1):77–86CrossRef Granieri MA, Peterson AC, Madden-Fuentes RJ (2017) Effect of lichen sclerosis on success of urethroplasty. Urol Clin N Am 44(1):77–86CrossRef
24.
Zurück zum Zitat Wang Q, Zhang SX, Chang MJ et al (2022) Characteristics of the gut microbiome and its relationship with peripheral CD4(+) T cell subpopulations and cytokines in rheumatoid arthritis. Front Microbiol 13:799602CrossRefPubMedPubMedCentral Wang Q, Zhang SX, Chang MJ et al (2022) Characteristics of the gut microbiome and its relationship with peripheral CD4(+) T cell subpopulations and cytokines in rheumatoid arthritis. Front Microbiol 13:799602CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Strauss J, Kaplan GG, Beck PL et al (2011) Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm Bowel Dis 17(9):1971–1978CrossRefPubMed Strauss J, Kaplan GG, Beck PL et al (2011) Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm Bowel Dis 17(9):1971–1978CrossRefPubMed
26.
Zurück zum Zitat Min KR, Galvis A, Baquerizo Nole KL et al (2020) Association between baseline abundance of peptoniphilus, a Gram-positive anaerobic coccus, and wound healing outcomes of DFUs. PLoS ONE 15(1):e0227006CrossRefPubMedPubMedCentral Min KR, Galvis A, Baquerizo Nole KL et al (2020) Association between baseline abundance of peptoniphilus, a Gram-positive anaerobic coccus, and wound healing outcomes of DFUs. PLoS ONE 15(1):e0227006CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Fistarol SK, Itin PH (2013) Diagnosis and treatment of lichen sclerosus: an update. Am J Clin Dermatol 14(1):27–47CrossRefPubMed Fistarol SK, Itin PH (2013) Diagnosis and treatment of lichen sclerosus: an update. Am J Clin Dermatol 14(1):27–47CrossRefPubMed
28.
Zurück zum Zitat Erickson BA, Tesdahl BA, Voznesensky MA et al (2018) Urethral lichen sclerosus under the microscope: a survey of academic pathologists. Can J Urol 25(3):9328–9333PubMed Erickson BA, Tesdahl BA, Voznesensky MA et al (2018) Urethral lichen sclerosus under the microscope: a survey of academic pathologists. Can J Urol 25(3):9328–9333PubMed
Metadaten
Titel
Urinary microbiome differences between lichen sclerosus induced and non-lichen sclerosus induced urethral stricture disease
verfasst von
Marcus L. Jamil
Aaron Perecman
Amanda Sherman
Travis Sullivan
Kimberly Christ
Alexandra Hansma
Eric Burks
Alex J. Vanni
Publikationsdatum
08.07.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 9/2023
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-023-04490-0

Weitere Artikel der Ausgabe 9/2023

World Journal of Urology 9/2023 Zur Ausgabe

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.